HPV Screening (Human Papilloma Virus)

HPV Testing Clinical Trial

— HPV  

Official title:

Screening for Human Papilloma Virus in Urine and Pap Smear.A Comparative Study.

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT02613611
• Other study ID #: Obgyn.. .. ..
• Status: Not yet recruiting
• Phase: N/A
• First received: November 21, 2015
• Last updated: November 21, 2015
• Start date: November 2015
• Est. completion date: March 2016

Study information

• Verified date: November 2015
• Source: Kasr El Aini Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Egypt: Ministry of Higher Education
• Study type: Observational

Clinical Trial Summary

Examination of cervical &urine samples for HPV

Description:

500 females attending colposcopy kasrelaini unit are included. History including age and parity is taken.urine samples are taken. Colposcopy will be done. Pap smear will be taken and sent for pathology.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 500
• Est. completion date: March 2016
• Est. primary completion date: March 2016
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• all females attending colposcopy kasrelaini unit aging 18_45 years

Exclusion Criteria:

• females with known cervical cancer

• females less than 18 or more than 45

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• HPV Testing

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Kasr El Aini Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of patients with positive urine test for HPV Number of patients with positive pap smear.		3 months	No